Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Meirong Huo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4653-3959; OpenAlex author ID A5031921143. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Microthrombi targeted nano-micelle synchronizing endothelial gap opening and matrix decompression for augmenting drug perfusion within pancreatic cancer. Co-author DOI 10.1016/j.apsb.2025.12.037↗
  2. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem. Last author DOI 10.1016/j.jconrel.2023.07.061↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mengnan Yang · 1 shared paper, 2026 · strength 0.29
  2. Tingjie Yin · 1 shared paper, 2026 · strength 0.29
  3. Wei Xu · 1 shared paper, 2023 · strength 0.20
  4. Xinyuan Zhou · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.